Mai Lan Leong

Title: Mai Lan Leong: Innovator in Neuropathic Pain Research

Introduction

Mai Lan Leong is a prominent inventor based in Minneapolis, MN (US). She has made significant contributions to the field of neuropathic pain research. Her innovative work focuses on methods to prevent or attenuate neuropathic pain using bile acids.

Latest Patents

Mai Lan Leong holds a patent titled "Prevention or attenuation of neuropathic pain by bile acids." This patent discusses methods of reducing or abolishing neuropathic pain in both humans and animals. In her research, the administration of the apoptosis inhibitor tauroursodeoxycholic acid (TUDCA) has shown promising results. It greatly reduced neuronal loss and the increase in glia, and partially reversed spinal nerve ligation (SNL)-induced mechanical hypersensitivity. The findings indicate that nerve injury induces the death of antinociceptive RVM neurons, which can be mitigated by TUDCA.

Career Highlights

Mai Lan Leong has made notable strides in her career, particularly in the area of pain management. Her research has provided valuable insights into the mechanisms of neuropathic pain and potential therapeutic approaches. She is currently associated with Meselex, Inc., where she continues her innovative work.

Collaborations

Mai Lan Leong collaborates with esteemed colleagues, including Martin Wessendorf and Clifford Steer. Their combined expertise enhances the research efforts in the field of neuropathic pain.

Conclusion

Mai Lan Leong is a trailblazer in the realm of neuropathic pain research, with her patent and collaborative efforts paving the way for future advancements. Her work holds the potential to significantly impact the treatment of neuropathic pain in both humans and animals.